NCT02821390View on ClinicalTrials.gov

Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Pain
Interventions
DRUG

Nepafenac Eye Drops

One drop instilled to the eye's cul de sac prior to the intravitreal injection.

DRUG

Placebo (Artificial Tears)

One drop instilled to the eye's cul de sac prior to the intravitreal injection

Trial Locations (1)

26504

University Hospital of Patras, Pátrai

All Listed Sponsors
lead

University Hospital of Patras

OTHER

NCT02821390 - Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections | Biotech Hunter | Biotech Hunter